Ngā hua rapu - Matthias Weckesser

  • E whakaatu ana i te 1 - 19 hua o te 19
Whakamahine hua
  1. 1
    The Diagnostic Imaging of Bone Metastases

    The Diagnostic Imaging of Bone Metastases mā Walter Heindel, Raphael Gübitz, Volker Vieth, Matthias Weckesser, Otmar Schober, Michael Schäfers

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Radioligand therapy using [177Lu]Lu-PSMA-617 in mCRPC: a pre-VISION single-center analysis

    Radioligand therapy using [177Lu]Lu-PSMA-617 in mCRPC: a pre-VISION single-center analysis mā Robert Seifert, Katharina Kessel, Katrin Schlack, Matthias Weckesser, Martin Bögemann, Kambiz Rahbar

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    5-Aminolevulinic Acid Fluorescence-Guided Resection of 18F-FET-PET Positive Tumor Beyond Gadolinium Enhancing Tumor Improves Survival in Glioblastoma

    5-Aminolevulinic Acid Fluorescence-Guided Resection of 18F-FET-PET Positive Tumor Beyond Gadolinium Enhancing Tumor Improves Survival in Glioblastoma mā Michael Müther, Raphael Koch, Matthias Weckesser, Peter B. Sporns, Wolfram Schwindt, Walter Stummer

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Contribution of PET/CT to Prediction of Outcome in Children and Young Adults with Rhabdomyosarcoma

    Contribution of PET/CT to Prediction of Outcome in Children and Young Adults with Rhabdomyosarcoma mā Sven Holger Baum, Michael C. Frühwald, Kambiz Rahbar, Johannes Weßling, Otmar Schober, Matthias Weckesser

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Second line chemotherapy and visceral metastases are associated with poor survival in patients with mCRPC receiving <sup>177</sup>Lu-PSMA-617

    Second line chemotherapy and visceral metastases are associated with poor survival in patients with mCRPC receiving <sup>177</sup>Lu-PSMA-617 mā Katharina Kessel, Robert Seifert, Michael Schäfers, Matthias Weckesser, Katrin Schlack, Martin Boegemann, Kambiz Rahbar

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Diagnostic performance of 18F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer

    Diagnostic performance of 18F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer mā Kambiz Rahbar, Ali Afshar‐Oromieh, Robert Seifert, Stefan Wagner, Michael Schäfers, Martin Bögemann, Matthias Weckesser

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients

    Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients mā Oliver Grauer, Mohammed Hammad Jaber, Katharina Heß, Matthias Weckesser, Wolfram Schwindt, Stephan Maring, Johannes Wölfer, Walter Stummer

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Correlation of Intraprostatic Tumor Extent with <sup>68</sup>Ga-PSMA Distribution in Patients with Prostate Cancer

    Correlation of Intraprostatic Tumor Extent with <sup>68</sup>Ga-PSMA Distribution in Patients with Prostate Cancer mā Kambiz Rahbar, Matthias Weckesser, Sebastian Huss, Axel Semjonow, Hans‐Jörg Breyholz, Andres J. Schrader, Michael Schäfers, Martin Bögemann

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving <sup>177</sup>Lu-PSMA-617 Radioligand Therapy

    Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving <sup>177</sup>Lu-PSMA-617 Radioligand Therapy mā Robert Seifert, Konstantin Seitzer, Ken Herrmann, Katharina Kessel, Michael Schäfers, Jens Kleesiek, Matthias Weckesser, Martin Boegemann, Kambiz Rahbar

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    The Value of 5-Aminolevulinic Acid in Low-grade Gliomas and High-grade Gliomas Lacking Glioblastoma Imaging Features

    The Value of 5-Aminolevulinic Acid in Low-grade Gliomas and High-grade Gliomas Lacking Glioblastoma Imaging Features mā Mohammed Hammad Jaber, Johannes Wölfer, Christian Ewelt, Markus Holling, Martin Hasselblatt, Thomas Niederstadt, Tarek Zoubi, Matthias Weckesser, Walter Stummer

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Differentiation of Malignant and Benign Cardiac Tumors Using <sup>18</sup>F-FDG PET/CT

    Differentiation of Malignant and Benign Cardiac Tumors Using <sup>18</sup>F-FDG PET/CT mā Kambiz Rahbar, Harald Seifarth, Michael Schäfers, Lars Stegger, A. Hoffmeier, Tilmann Spieker, Klaus Tiemann, David Maintz, Hans H. Scheld, Otmar Schober, Matthias Weckesser

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis

    PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis mā Robert Seifert, Katharina Kessel, Katrin Schlack, Manuel Weber, Ken Herrmann, Maximilian Spanke, Wolfgang P. Fendler, Boris Hadaschik, Jens Kleesiek, Michael Schäfers, Matthias Weckesser, Martin Boegemann, Kambiz Rahbar

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Nivolumab in a patient with refractory Hodgkin’s lymphoma after allogeneic stem cell transplantation

    Nivolumab in a patient with refractory Hodgkin’s lymphoma after allogeneic stem cell transplantation mā Linus Angenendt, Christoph Schliemann, Mathias Lutz, Elisabeth Rebber, Arik Bernard Schulze, Matthias Weckesser, Lars Stegger, Michael Schäfers, Christoph Groth, Torsten Keßler, Georg Lenz, Matthias Stelljes, Wolfgang E. Berdel

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Detection and differentiation of inflammatory versus fibromatous Crohnʼs disease strictures: Prospective comparison of 18F-FDG-PET/CT, MR-enteroclysis, and transabdominal ultrasound versus endoscopic/histologic evaluation

    Detection and differentiation of inflammatory versus fibromatous Crohnʼs disease strictures: Prospective comparison of 18F-FDG-PET/CT, MR-enteroclysis, and transabdominal ultrasoun... mā Frank Lenze, Johannes Weßling, Janbernd Bremer, Hansjoerg Ullerich, Tillmann Spieker, Matthias Weckesser, Sarid Gonschorrek, Klaus Kannengieer, Emile Rijcken, Jan Heidemann, Andreas Luegering, Otmar Schober, Wolfram Domschke, Torsten Kucharzik, Christian Maaser

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Translational <sup>18</sup>F-FDG PET/CT Imaging to Monitor Lesion Activity in Intestinal Inflammation

    Translational <sup>18</sup>F-FDG PET/CT Imaging to Monitor Lesion Activity in Intestinal Inflammation mā Dominik Bettenworth, Stefan Reuter, Sven Hermann, Matthias Weckesser, Linda Kerstiens, Athanasios Stratis, Tobias M. Nowacki, Matthias Ross, Frank Lenze, Bayram Edemir, Christian Maaser, Thomas Pap, Steffen Koschmieder, Jan Heidemann, Michael Schäfers, Andreas Lügering

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Translational imaging of the fibroblast activation protein (FAP) using the new ligand [68Ga]Ga-OncoFAP-DOTAGA

    Translational imaging of the fibroblast activation protein (FAP) using the new ligand [68Ga]Ga-OncoFAP-DOTAGA mā Philipp Backhaus, F. Gierse, Matthias C. Burg, Florian Büther, Inga Asmus, P. Dorten, J. Cufe, Wolfgang Roll, Dario Neri, Samuele Cazzamalli, Jacopo Millul, Jacqueline Mock, Andrea Galbiati, Aureliano Zana, K. P. Schäfers, Sven Hermann, Matthias Weckesser, J Tio, Stefan Wagner, Hans‐Jörg Breyholz, Michael Schäfers

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma

    Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stag... mā Carsten Kobe, Markus Dietlein, Jeremy Franklin, Jana Marková, Andreas Lohri, Holger Amthauer, Susanne Klutmann, Wolfram H. Knapp, Josée M. Zijlstra, Andreas Bockisch, Matthias Weckesser, R. Lorenz, Mathias Schreckenberger, Roland Bares, Hans Theodor Eich, Rolf‐Peter Mueller, Michael Fuchs, Peter Borchmann, H Schicha, Volker Diehl, Andreas Engert

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUV<sub>max</sub> Method

    Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUV<sub>max</sub> Method mā Jan Rekowski, Andreas Hüttmann, Christine Hanoun, Stefan Müller, Lars Kurch, Jörg Kotzerke, Christiane Franzius, Matthias Weckesser, Frank M. Bengel, Martin Freesmeyer, A. Hertel, Thomas Krohn, Jens Holzinger, Ingo Brink, Uwe Haberkorn, Fonyuy Nyuyki, Daniëlle M. E. van Assema, Lilli Geworski, Dirk Hasenclever, Karl‐Heinz Jöckel, Ulrich Dührsen

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma

    Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma mā Konstantin Agelopoulos, Günther Richter, Eva Marina Schmidt, Uta Dirksen, Kristina von Heyking, Benjamin Moser, Hans‐Ulrich Klein, Udo Kontny, Martin Dugas, Kathrin Poos, Eberhard Korsching, Thorsten Buch, Matthias Weckesser, Isabell Schulze, Regina Besoke, Anika Witten, Monika Stoll, Gabriele Köhler, Wolfgang Hartmann, Eva Wardelmann, Claudia Rössig, Daniel Baumhoer, Heribert Jürgens, Stefan Burdach, Wolfgang E. Berdel, Carsten Müller‐Tidow

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: